September 18, 2014 6:27 AM ET

Company Overview of Pancreatic Cancer Action Network, Inc.

Company Overview


United States

Key Executives for Pancreatic Cancer Action Network, Inc.

Chief Executive Officer and President
Vice President of Scientific and Medical Affairs
Compensation as of Fiscal Year 2014.

Pancreatic Cancer Action Network, Inc. Key Developments

The Pancreatic Cancer Action Network Announces Appointments to Scientific Advisory Board

The Pancreatic Cancer Action Network to welcome three new members to its prestigious Scientific Advisory Board: Sunil Hingorani, MD, PhD, Fred Hutchinson Cancer Research Center, Seattle, WA; Kimberly Kelly, PhD, University of Virginia, Charlottesville, VA; and Steven Leach, MD, Johns Hopkins University, Baltimore, MD. Vincent Picozzi, MD, Virginia Mason Medical Center, Seattle, WA, was appointed chair of the organization's Medical Advisory Board. Dr. Hingorani played a lead role in the development of the first genetically engineered mouse model of pancreatic cancer that accurately recapitulates the human disease. Dr. Kelly's work focuses on imaging techniques to improve early detection and diagnosis of pancreatic cancer. Based on findings funded by organization, Dr. Kelly has cofounded a biotechnology company and is currently conducting an early-phase clinical trial to test her noninvasive early detection biomarker. Dr. Leach looks at the early development of the normal pancreas to provide clues to how tumors arise. He also studies the earliest stages of pancreatic cancer initiation to discover better methods to detect and treat the disease before it has progressed to become more aggressive. Dr. Picozzi has been the principal investigator on a number of other clinical trials in pancreatic cancer. Dr. Picozzi joined the Pancreatic Cancer Action Network's Medical Advisory Board in 2008.

The Pancreatic Cancer Action Network Announces Executive Changes

The Pancreatic Cancer Action Network announced Laurie MacCaskill has been appointed Chair of the National Board of Directors of the organization, effective July 1. MacCaskill is the first pancreatic cancer patient to hold this position. The organization has also appointed Jeanne Ruesch to Vice Chair effective July 1. Ruesch serves on the board in honor of her late husband, Otto J. Ruesch.

Pancreatic Cancer Action Network, Inc. Announces Appointment of Members to Medical Advisory Board

Pancreatic Cancer Action Network, Inc. has named four new members to the organization's medical advisory board. The newest advisors are clinicians in the field of pancreatic cancer: Joseph M. Herman, MD, MSc, Johns Hopkins University, George A. Fisher Jr., MD, PhD, Stanford University, James Farrell, MD, Yale University and Philip Agop Philip, MD, PhD, Karmanos Cancer Center.

Similar Private Companies By Industry

Company Name Region
Bostick Murphy & Co Cpas PC United States
Coban Technologies, Inc. United States
graffitiGeo, Inc. United States
DMB Circle Road Partners, LLP United States
Overton Square Investors LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Pancreatic Cancer Action Network, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at